October 11, 2017

IN RE: Onglyza (Saxagliptin) and Kombiglyze XR (Saxagliptin and Metformin) Products Liability Litigation

Track this case

Case Number:



Judicial Panel on Multidistrict Litigation

Nature of Suit:


Karen K. Caldwell

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. January 25, 2018

    Patients Seek Calif. MDL In Suits Over Diabetes Drugs

    Diabetes patients suing Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP over diabetes drugs Onglyza and Kombiglyze told the U.S. Judicial Panel on Multidistrict Litigation in Miami Thursday that coordination on discovery has not worked well so far and asked to consolidate their cases in the Northern District of California.


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!